Moreover, it has been reported that primary pulmonary hypertension patients have an intrinsic reduced level of KCNA5 mRNA in their PASMCs, and this characteristic might play an important role in the pathogenesis of the disease [18]. This evidence concerns the gene KCNA5 and pulmonary arterial hypertension.